Cystic Fibrosis: all 1,605 studies
Page 7 of 17. Open to participants first (196), then studies with results posted, then the rest; newest registration first within each.
- An Electrocardiogram Study to Evaluate the Effect of Vanzacaftor on the QT/QTc Interval in Healthy ParticipantsCompletedNCT05867147Phase 1
- Virtual Reality Based Tele-Exercises on Exercise Capacity in Cystic FibrosisCompletedNCT05850351Not applicable
- Health Outcomes of Parents With Cystic FibrosisCompletedNCT05829694
- Use of A-STEP Test in Cystic Fibrosis PatientsStatus unknownNCT05809492Not applicable
- PEP and OPEP Devices in Cystic FibrosisStatus unknownNCT05801952Not applicable
- TAAI Erasmus Research Initiative to Fight CF: Monitoring Inflammation in CF Lung Disease Into a New EraCompletedNCT05752019
- COVID-19 ANtibody Responses in Cystic Fibrosis: CAR-CFCompletedNCT05745948
- Volatilomic Approaches for the Study of CFTR Modulators (VOLATIL-CF)CompletedNCT05726994
- Safety, Tolerability, and Pharmacokinetics of ARCT-032 in Healthy Adult Subjects and Adults With Cystic Fibrosis.CompletedNCT05712538Phase 1
- Hypoglycemia and Glucagon Response in CFCompletedNCT05700604
- Gut Imaging for Function and Transit in Cystic Fibrosis 3 JuniorStatus unknownNCT05699148
- Baby Detect : Genomic Newborn ScreeningCompletedNCT05687474
- A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF)CompletedNCT05668741Phase 1/2
- Effectiveness of CFTR Modulators According to Co-therapyStatus unknownNCT05663255
- Effects of Breathing Exercises Combined With Endurance and Strength Training in Patients With Cystic Fibrosis.CompletedNCT05655637Not applicable
- Combating Diagnostic Wandering and Impasse for Cystic FibrosisStatus unknownNCT05654480
- Study to Determine the Efficacy&Safety of ARV-1801(ACG-701) for the Treatment of Cystic Fibrosis Pulmonary ExacerbationsWithdrawnNCT05641298Phase 2
- Strength and Muscle Related Outcomes for Nutrition and Lung Function in CFActive, not recruitingNCT05639556
- COVID-19 Antibody Responses in Cystic FibrosisCompletedNCT05614336Not applicable
- Clinical and Genetic Profile of Pediatric Patients With Cystic Fibrosis in Sohag.CompletedNCT05599958
- Daily Monitoring of Respiratory Symptoms and Spirometry During ETI Treatment in Persons With Cystic Fibrosis.Status unknownNCT05599230
- Effects of Telerehabilitation-based Exercises in Cystic FibrosisCompletedNCT05590169Not applicable
- Clinical Performance of the AtbFinder® Test System for Selection of Antibiotic Therapy in Persons With Cystic FibrosisCompletedNCT05584982Not applicable
- Evaluation of the Evolution of Quality of Life in Relation to Naso-sinus Symptomatology Under Treatment With CFTE Modulators in Children Aged 6 to 11 Years With Cystic Fibrosis With Compatible MutationCompletedNCT05581056
- Effect of the CFTR-modulating Triple Therapy Elexacaftor - Tezacaftor - IvacaftorStatus unknownNCT05576324
- Alternate Measures of Glucose During OGTT Testing for CFRDCompletedNCT05568134
- COVID-19 Antibody Responses in Cystic FibrosisActive, not recruitingNCT05561868
- Imipenem/Cilastatin/Relebactam Pharmacokinetics, Safety, and Outcomes in Adults and Adolescents With Cystic FibrosisTerminatedNCT05561764Phase 4
- A Study to Evaluate the Relative Bioavailability of a Fixed-dose Combination Tablet of VX-121/Tezacaftor/DeutivacaftorCompletedNCT05535959Phase 1
- A Study to Assess the Pharmacokinetics and Safety of Co-administered Oral Galicaftor, Navocaftor, and ABBV-576 in Healthy Adults for the Treatment of Cystic FibrosisCompletedNCT05530278Phase 1
- Real-world Efficacy and Safety of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Therapy in Adult Patients With Cystic Fibrosis (CF)Status unknownNCT05526027Not applicable
- Inhaled Therapy Adherence and Outcomes to Kaftrio in Cystic FibrosisCompletedNCT05519020
- BEGIN Novel ImagiNG BiomarkersActive, not recruitingNCT05517655Phase 4
- Physical Activity Levels of Parents of Children With Cystic Fibrosis- (PHACTS-CF)Status unknownNCT05493137
- Pilot Trial of ExACT (Exercise as Airway Clearance Therapy) for People With Cystic FibrosisActive, not recruitingNCT05482048Not applicable
- The Impact Of A Tele-Exercise Program For Children With Cystic Fibrosis During The Covid-19 Pandemic On Quality Of LifeCompletedNCT05481190Not applicable
- PlayPhysio: Making Physio FunCompletedNCT05469711Not applicable
- Real-Time Assessment of Lung Structure and Function in Children and Young Adults With CF Using Electrical Impedance TomographyCompletedNCT05455671
- A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination TherapyActive, not recruitingNCT05444257Phase 3
- Pharmacokinetics and Safety Assessment of VX-121/Tezacaftor/Deutivacaftor in Participants With Moderate Hepatic ImpairmentCompletedNCT05437120Phase 1
- Evaluation of VX-121/Tezacaftor/Deutivacaftor in Cystic Fibrosis (CF) Participants 1 Through 11 Years of AgeActive, not recruitingNCT05422222Phase 3
- Pilot Study to Evaluate a Voice Journaling Application in Adolescents With Cystic FibrosisCompletedNCT05420844Not applicable
- Rifaximin for Treatment of Bloating in Children and Adults With Cystic FibrosisWithdrawnNCT05408910Phase 2/3
- Explore the Sharing Model Intervene to Improve the Knowledge, Attitudes, Service Intentions and Service Start-up Effects of the Eight Major Non-cancer Disease End-stage Caregivers on Well-being and Palliative CareCompletedNCT05407272Not applicable
- Symptom Based Performance of Airway Clearance After Starting Highly Effective Modulators for Cystic Fibrosis (SPACE-CF)TerminatedNCT05392855Not applicable
- Performance and Patient Acceptance of a Commercially Available Beverage as Compared to an Oral Glucose Solution for Oral Glucose Tolerance Tests in Cystic Fibrosis (CF) Patients Who Are Screened for CF-related Diabetes.Status unknownNCT05377502
- Colorectal Cancer Screening in Cystic FibrosisActive, not recruitingNCT05362344
- Platelets in Cystic Fibrosis Lung InflammationCompletedNCT05339724
- Study to Evaluate Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) Long-term Safety and Efficacy in Subjects Without F508delActive, not recruitingNCT05331183Phase 3
- Cefiderocol Pharmacokinetics in Adult Patients With Cystic FibrosisCompletedNCT05314764Phase 4
- Description of the Short-term Effects of KAFTRIO® by Continuous Monitoring With the PHEAL-CR-K Application in Real Life in Patients With Cystic Fibrosis Eligible for KAFTRIO® TreatmentStatus unknownNCT05295524Not applicable
- An Assistive Powered Wheelchair: Stage 2 TrialCompletedNCT05292690
- Observational Study Comparing Home to Office SpirometryCompletedNCT05285410
- Efficacy of Intensive Cholecalciferol Monitoring and Supplementation on Serum vitD Levels in Pediatric Patients With CFCompletedNCT05276960Phase 4
- Pilot Study of a CF-specific CBT Intervention for AdolescentsCompletedNCT05271643Not applicable
- Effects of Automated Oxygen Titration Alone or With High Flow Nasal Therapy on Dyspnea and Exercise ToleranceTerminatedNCT05267418Not applicable
- CFTR Modulators and Gastrointestinal ComplicationsCompletedNCT05253859
- A Comprehensive Approach To Relief Of Digestive Symptoms In Cystic Fibrosis: CARDS-CFCompletedNCT05251467
- Relationship Between the Development of Impaired Glucose Tolerance, the Phenotype of CFLD, and the Risk of Liver FibrosisWithdrawnNCT05229640Not applicable
- Gastroparesis in Cystic FibrosisWithdrawnNCT05223881Not applicable
- COVID-19 Antibody Responses in Cystic Fibrosis (CAR-CF)Status unknownNCT05217784
- Determinants of Daily Physical Activity Level in Patients With Cystic Fibrosis - Pilot Study ProtocolActive, not recruitingNCT05206097Not applicable
- Psychosocial Factors and Quality of Life in the Effect of Fear of COVID-19 With Cystic FibrosisCompletedNCT05195216
- Remotely Supervised Exercise for Adults With Cystic FibrosisCompletedNCT05173194Not applicable
- COVID-19 Antibody Responses In Cystic FibrosisStatus unknownNCT05158829
- The Relationship Between CFTR Gene Mutations and Exercise CapacityWithdrawnNCT05157646Not applicable
- Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis (CF) Participants 2 Years and OlderCompletedNCT05153317Phase 3
- The Effect of Telerehabilitation on Functional Capacity, Oxidative Stress and Respiratory Parameters in Cystic FibrosisCompletedNCT05147285Not applicable
- Effects of Training Intensity on Physical Fitness and Body Composition in Cystic FibrosisCompletedNCT05140967Not applicable
- Study of a Nebulised Nitric Oxide Generating Solution in Patients With Mycobacterium AbscessusTerminatedNCT05101915Phase 2
- Validation of Therapeutic Efficacy Targeting the Splicing Variants in Cystic Fibrosis and CFTR PathologiesTerminatedNCT05100823Not applicable
- A Study of Inhaled KB407 for the Treatment of Cystic FibrosisWithdrawnNCT05095246Phase 1
- A Study to Investigate Cystic Fibrosis Pulmonary Exacerbations and the Lung MicrobiomeTerminatedNCT05088447
- COVID-19 Antibody Responses In Cystic FibrosisCompletedNCT05074680
- COVID-19 Antibody Responses In Cystic Fibrosis: CAR-CFCompletedNCT05054582
- COVID-19 Antibody Responses in Cystic FibrosisActive, not recruitingNCT05052294
- Pre-emptive Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Cystic Fibrosis Related Liver DiseaseCompletedNCT05037643Not applicable
- Ovarian Reserve in Women With Cystic Fibrosis and the Correlation With Demographic and Clinical ParametersStatus unknownNCT05029817
- Effectiveness of the Hippotherapy Simulator in Children and Adolescents with Cystic FibrosisCompletedNCT05027503Not applicable
- Manual Chest Physiotherapy and Active Cycle of Breathing Techniques (ACBT) in Patients of Cystic FibrosisCompletedNCT05026918Not applicable
- Covid-19 Antibody Responses in Cystic FibrosisActive, not recruitingNCT05012306
- Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary InfectionCompletedNCT05010577Phase 1/2
- Renal Failure Following Lung Transplantation in Cystic Fibrosis PatientsCompletedNCT05001841
- Cystic Fibrosis Reproductive and Sexual Health Collaborative: Building Online Research PartnershipsStatus unknownNCT04999865
- Evaluation of Lung T1-MRI in Pediatric Cystic Fibrosis PatientsCompletedNCT04994301
- COVID-19 Antibody Responses in Cystic FibrosisCompletedNCT04992234
- Effect of Antioxidant Docosahexaenoic Acid (DHA) in Cystic Fibrosis PatientsCompletedNCT04987567Not applicable
- Cystic Fibrosis Blood NeutrophilsCompletedNCT04970225Not applicable
- Assessment of a PERT-free Nutritional Therapeutic Delivery System for Cystic FibrosisCompletedNCT04966897Not applicable
- A New Posaconazole Dosing Regimen for Paediatric Patients With Cystic Fibrosis and Aspergillus InfectionStatus unknownNCT04966234Phase 2/3
- Bottle PEP in Cystic FibrosisCompletedNCT04961008Not applicable
- A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled ETD001 in Healthy SubjectsCompletedNCT04926701Phase 1
- Pragmatic Implementation Trial of a CF Primary Palliative Care InterventionCompletedNCT04923880Not applicable
- A Decentralized Study to Evaluate Physical Activity and Cough Frequency Using Wearable Technology in Cystic FibrosisCompletedNCT04923464
- COVID-19 Antibody Responses In Cystic FibrosisCompletedNCT04904445
- Relationship of Skeletal Muscle Thickness, Strength, and Diaphragm Function in Adults With CFCompletedNCT04892485
- Training in Shared Decision-making of Cystic Fibrosis Centers Competences in the Treatment of CF Related Diabetes in Adult PatientsStatus unknownNCT04891159
- Safety and Feasibility of High-intensity Interval Training Program in CF PatientsCompletedNCT04888767Not applicable
- General Health, Attitudes, and Activity in Self-directed Exercise in Patients With Cystic Fibrosis (GAINS-CF)Status unknownNCT04882267Not applicable
- Epidemiology of Anaerobic Bacteria in Cystic Fibrosis Patients: Descriptive and Non-interventional StudyCompletedNCT04879381